National Biodefense Science Board; Public Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The National Biodefense Science Board (NBSB or the Board), authorized under Section 319M of the Public Health Service (PHS) Act, as added by Section 402 of the Pandemic and All-Hazards Preparedness Act of 2006 and amended by Section 404 of the Pandemic and All-Hazards Preparedness Reauthorization Act, will hold a virtual, public meeting on March 9, 2023. The NBSB provides expert advice and guidance to the Department of Health and Human Services (HHS) regarding current and future chemical, biological, radiological, and nuclear threats, as well as other matters related to disaster preparedness and response. The Administration for Strategic Preparedness and Response (ASPR) manages and convenes the NBSB on behalf the Secretary of HHS. The NBSB public meeting will beginning at 11:00 a.m. Eastern time. A detailed agenda and Zoom registration instructions will be available on the ASPR website. Procedures for Public Participation: The link to pre-register for the public meeting will be posted on the meeting website. The online meeting, which use a webinar format, will include American Sign Language interpretation and live captioning. Members of the public may provide written comments or submit questions at any time via email to NBSB@hhs.gov. Additionally, the NBSB invites stakeholders to request up to seven minutes to address the Board in-person during the meeting. The Board wishes to hear from experts from relevant biomedical, biodefense, or health industries; faculty or researchers at academic institutions; health professionals, health system experts, or those who work in health care consumer organizations; or experts in state, Tribal, territorial, or local government agencies. Requests to provide remarks to the NBSB during the public meeting must be sent to NBSB@hhs.gov by March 2, 2023. In that request, please provide the speaker's name, title, position, and organization, with a brief description of the topic that they will address. Requests to speak to the Board will be approved in consultation with the Board Chair and based on time available during the meeting.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 16 (Wednesday, January 25, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 16 (Wednesday, January 25, 2023)]
[Notices]
[Pages 4832-4833]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-01460]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Biodefense Science Board; Public Meeting
AGENCY: Administration for Strategic Preparedness and Response (ASPR),
Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Biodefense Science Board (NBSB or the Board),
authorized under Section 319M of the Public Health Service (PHS) Act,
as added by Section 402 of the Pandemic and All-Hazards Preparedness
Act of 2006 and amended by Section 404 of the Pandemic and All-Hazards
Preparedness Reauthorization Act, will hold a virtual, public meeting
on March 9, 2023. The NBSB provides expert advice and guidance to the
Department of Health and Human Services (HHS) regarding current and
future chemical, biological, radiological, and nuclear threats, as well
as other matters related to disaster preparedness and response. The
Administration for Strategic Preparedness and Response (ASPR) manages
and convenes the NBSB on behalf the Secretary of HHS. The NBSB public
meeting will beginning at 11:00 a.m. Eastern time. A detailed agenda
and Zoom registration instructions will be available on the ASPR
website.
Procedures for Public Participation: The link to pre-register for
the public meeting will be posted on the meeting website. The online
meeting, which use a webinar format, will include American Sign
Language interpretation and live captioning.
Members of the public may provide written comments or submit
questions at any time via email to <a href="/cdn-cgi/l/email-protection#d09e92839290b8b8a3feb7bfa6"><span class="__cf_email__" data-cfemail="145a564756547c7c673a737b62">[email protected]</span></a>. Additionally, the NBSB
invites stakeholders to request up to seven minutes to address the
Board in-person during the meeting. The Board wishes to hear from
experts from relevant
[[Page 4833]]
biomedical, biodefense, or health industries; faculty or researchers at
academic institutions; health professionals, health system experts, or
those who work in health care consumer organizations; or experts in
state, Tribal, territorial, or local government agencies. Requests to
provide remarks to the NBSB during the public meeting must be sent to
<a href="/cdn-cgi/l/email-protection#a4eae6f7e6e4ccccd78ac3cbd2"><span class="__cf_email__" data-cfemail="8ec0ccddcccee6e6fda0e9e1f8">[email protected]</span></a> by March 2, 2023. In that request, please provide the
speaker's name, title, position, and organization, with a brief
description of the topic that they will address. Requests to speak to
the Board will be approved in consultation with the Board Chair and
based on time available during the meeting.
FOR FURTHER INFORMATION CONTACT: CAPT Christopher Perdue, NBSB
Designated Federal Official, (202) 480-7226, <a href="/cdn-cgi/l/email-protection#054b475647456d6d762b626a73"><span class="__cf_email__" data-cfemail="2b656978696b434358054c445d">[email protected]</span></a>.
Dawn O'Connell,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2023-01460 Filed 1-24-23; 8:45 am]
BILLING CODE 4150-37-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.